RxSight, Inc. (RXST)
NGM · Common · CUSIP 78349D107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RXST and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
78349D107
Market Cap
Small Cap · $380 Million
IPO
7/30/2021 · $16.00/share
Business: RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens, RxSight Light Delivery Device and accessories, is the first and only commercially available intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.

Company Contact

CEO
Ron Kurtz
CFO
Shelley Thunen
Headquarters
100 Columbia, Aliso Viejo, CA 92656
Phone
949-521-7830
Investor Relations
Philip Taylor, Gilmartin Group · 415-937-5406 · ir@rxsight.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »